ARCHIVES

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

No Recision Seen, New Money To Low In Mid-March

February 20, 1976

NCI To Offer New Grants In Preventative Oncology -Epidemiology, Biostatistics

October 26, 1979

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

Study Explores Reasons Women Avoid Mammograms

February 25, 2011